Concepedia

Ru Si

RS

Statistics

Publications

8

Citations

205

H-Index

8

Active since

2017

Affiliations

Xi'an Jiaotong University(Current)

First Affiliated Hospital of Xi'an Jiaotong University

Georgia State University

Ru Si is an author at Xi'an Jiaotong University specializing in angiogenesis, drug discovery, and pharmacology.

Publications per year

2017–2023

8

Publications

8

Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1 H -indazole-3-amine as multi-target RTKs inhibitors

Yuanyuan Shan, Chuansheng Li, Ru Si et al. · European Journal of Medicinal Chemistry · 2017 · 42 citations · Full text

, , +14

Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents

Lin Zhang, Yuanyuan Shan, Xingyue Ji et al. · Oncotarget · 2017 · 36 citations · Full text

, , +17

Discovery of novel anti-angiogenesis agents. Part 11: Development of PROTACs based on active molecules with potency of promoting vascular normalization

Yuanyuan Shan, Ru Si, Jin Wang et al. · European Journal of Medicinal Chemistry · 2020 · 28 citations · Full text

, , +10

Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction

Ru Si, Ping Hai, Yongbiao Zheng et al. · European Journal of Medicinal Chemistry · 2023 · 25 citations

, , +14

Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol

Xiaoyan Pan, Liyuan Liang, Ru Si et al. · European Journal of Medicinal Chemistry · 2018 · 22 citations · Full text

, , +13

1–5 of 8